Author:
Feng Xiu,Gu Qingwei,Gao Gu,Yuan Lu,Li Qian,Zhang Ying
Funder
Jiangsu Natural Science Foundation
Jiangsu Planned Projects of Postdoctoral Research Funds
Peak of Six Personnel
Nanjing Medical Science and Technique Development Foundation
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism
Reference28 articles.
1. Association, American, Cardiovascular disease and risk management: standards of medical care in diabetes-2019;Diabetes Care,2019
2. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes;Nissen;N Engl J Med,2007
3. Sodium-glucose co-transport inhibitors: progress and therapeutic potential in type 2 diabetes mellitus;Neumiller;Drugs,2010
4. Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors;Mulvihill;Endocr Rev,2014
5. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献